Drug Profile
Chronic lymphocytic leukaemia vaccine - MaxCyte
Alternative Names: Gene modified autologous B-CLL cell therapy - MaxcyteLatest Information Update: 21 Sep 2015
Price :
$50
*
At a glance
- Originator MaxCyte
- Developer Baylor College of Medicine
- Class Cancer vaccines
- Mechanism of Action CD40 ligand stimulants; Immunostimulants; Interleukin-2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Chronic lymphocytic leukaemia